The Ministry of Public Health, Thailand, and the World Hepatitis Alliance, in collaboration with the World Health Organization, will convene the 5th World Hepatitis Summit 2026 under the theme of “Elimination for everyone, everywhere, right now!” on 28 to 30 April 2026 in Bangkok, Thailand.
The Summit will focus on the strategies and actions needed to achieve the goal of hepatitis elimination at both national and global levels. It is a high-profile international event that brings together policymakers, high level government officials, civil society groups and people with lived experience, medical professionals, WHO and other UN agencies, international development partners and representatives from the private sector.
Our Executive Director Midnight will be speaking at:
Workshop: Innovative community-led responses
Date: Wednesday, 29 April 2026
Session start time: 11:00
L-R – Midnight (APCOM Executive Director), Cary James (World Hepatitis Alliance Chief Executive), Jessica Hicks (World Hepatitis Alliance Senior Director), Steve Shaw (Communications and Marketing Manager)
“As a member of the World Hepatitis Alliance, it is a pleasure to be able to share our work at the up-coming World Hepatitis Summit,”
commented APCOM Executive Director, Midnight,
“We are known for our online and social media outreach, and will be profiling our TestXXX which is regional behaviour change communication campaign that aims to increase the HIV services uptake among young gay men in cities with high HIV prevalence in Asia.”
Through its pilot TestBKK, the community-led model has expanded to other cities in Asia in Hong Kong, India, Indonesia, Laos, Mongolia, Nepal, the Philippines, and Vietnam.
The TestBKK site has a dedicated page on Hepatitis B, as Hepatitis B and HIV are strongly linked by shared transmission routes—primarily unprotected sex and injection drug use—resulting in a roughly 10% co-infection rate globally. HIV accelerates HBV progression, leading to higher rates of chronic liver disease, cirrhosis, and cancer. Early screening and combined ART are critical, as HBV is a leading cause of death in people living with HIV.
